Estrella Immunopharma
$0.84
0
+$0+0% Hari ini
Statistik
Harga Tertinggi Hari Ini
0.89
Harga Terendah Hari Ini
0.82
52M Tinggi
3.23
52M Rendah
0.77
Volume
12,381
Rata-Rata Volume
200,173
Kap Pasar
40.01M
Rasio P/E
-
Hasil Dividen
-
Dividen
-
Orang Juga Mengikuti
Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti ESLA. Ini bukan rekomendasi investasi.
Peserta
Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Tentang
Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.
Show more...
CEO
Negara
US
ISIN
US2975841048